Literature DB >> 655127

The nature of the receptor for complement (C3b) in the human renal glomerulus.

J R Carlo, R B Nagle, M L Shin.   

Abstract

The physicochemical nature of the human glomerular complement receptor was studied. Receptor activity was measured by determining the avidity of glomeruli of normal human renal tissue for fluorescein-labeled bacteria (S.typhi) coated with C3b. Maximal binding of C3b-coated bacteria to normal human glomeruli took place in phosphate-saline buffers of pH 6.5 and 0.08 to 0.15 mu ionic strength. Pretreatment of renal tissue with neuraminidase enhanced receptor activity. On the other hand, binding of C3b-coated bacteria to the glomeruli was diminished by pretreatment of the tissue with proteolytic enzymes, phospholipase C and certain lipid solvents. The binding of C3b-coated bacteria to the glomeruli was also diminished by pretreatment of the tissue with fluid-phase C3b, or by pretreatment of the bacteria with C3b inactivator. Normal human serum and purified fluid-phase C3 or the absence of magnesium and calcium ions had little effect on glomerular complement receptor activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 655127     DOI: 10.1093/ajcp/69.5.486

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Complement receptors on normal human lymphocytes containing parallel tubular arrays.

Authors:  C M Payne; R B Nagle
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

2.  Tissue C3b receptors.

Authors:  L Schrieber; R Penny
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

3.  Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.

Authors:  M D Kazatchkine; D T Fearon; M D Appay; C Mandet; J Bariety
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

4.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16

5.  Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis.

Authors:  D Koffler; G Biesecker; B Noble; G A Andres; A Martinez-Hernandez
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.